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VIEWPOINTS
Angiography- Derived Fractional Flow 
Reserve: More or Less Physiology?
Paul D. Morris , PhD, MRCP; Nick Curzen, PhD, FRCP; Julian P. Gunn, MD, MRCP
E
vidence robustly demonstrates that ischemia, 
rather than anatomy, is the optimal target for coro-
nary revascularization. In the cardiac catheter labo-
ratory, fractional flow reserve (FFR) and corresponding 
diastolic indices are regarded as the gold standard for 
physiological lesion assessment and ischemia detec-
tion (Table 1). Yet, despite a wealth of supporting data 
and indications in international guidelines, the use of 
FFR remains surprisingly low in the diagnostic assess-
ment of coronary artery disease across the world.1,2 To 
address this, multiple groups have developed methods 
for computing FFR from invasive angiography, without 
the need for passing a pressure wire or inducing hy-
peremia, thus removing the main barriers to uptake. 
Angiography- derived FFR therefore has the potential 
to extend the benefits of physiological coronary lesion 
assessment to considerably more patients. Given the 
size of the interventional cardiology market, clinical and 
commercial motivation to deliver these tools as quickly 
as possible could hardly be greater. Several models 
are now approved as medical devices. Imminently, 
physicians and healthcare providers will have to decide 
whether to use these tools. But do they truly deliver 
physiology, and are they accurate enough? There are 3 
particular areas of that deserve close scrutiny.
SIMPLIFICATION
Methods for computing angiography- derived FFR are 
software based. Three- dimensional arterial anatomy is 
reconstructed from paired 2- dimensional angiogram 
images. Mathematical equations that define hemody-
namic laws are then applied to the reconstructed ar-
tery to predict the pressure dynamics along the artery, 
which are displayed as a color- mapped 3- dimensional 
artery. In an effort to rationalize these models to make 
them practical and expedient for clinical use, many 
groups have abandoned complex, numerical, compu-
tational fluid dynamics simulation in favor of analyti-
cal solutions based broadly upon the laws of Bernoulli 
and/or Poiseuille. These simpler physical laws char-
acterize pressure losses attributable to convective 
acceleration and viscous friction, respectively. They 
are quick and simple to execute and perform well 
under steady (nonpulsatile), laminar flow conditions, in 
straight conduits. Coronary arteries, however, are not 
straight, and flow is pulsatile. Furthermore, these laws 
are unable to accurately characterize complex trans-
lesional pressure dynamics, particularly poststenosis 
pressure recovery, which is the basis of FFR. Some 
stenosis models make empiric assumptions or cor-
rections for pressure loss and recovery. On average, 
these may perform adequately, but cannot represent 
the potentially complex flow patterns in a specific 
case. Moreover, they may be particularly vulnerable to 
inaccuracy in the context of serial lesions and diffuse 
disease in which 3- dimensional computational fluid 
dynamics computations more reliably characterize in-
terstenosis hemodynamic interaction. The impact this 
has on accuracy, in all disease patterns, is yet to be 
fully determined.
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ASSUMPTIONS
The discordance between angiographic severity and 
physiological (FFR) significance is well described and 
affects ≥30% of lesions. Discrepancies occur be-
cause, unlike angiography, FFR elegantly and auto-
matically incorporates the combined and inter- related 
effects of coronary flow and microvascular resistance. 
It is therefore imperative that computational models 
of angiography- derived FFR include adequate physi-
ological inputs or “tuning” to represent the maximum 
blood flow or minimum microvascular resistance; the 
latter dictates the former, which, in turn, dictates the 
pressure gradient and FFR. Hemodynamic equations 
are capable of accurately deriving a variety of physi-
ological parameters, but only if other appropriate 
physiological inputs, such as flow or microvascular 
resistance, are included. A sensitivity analysis dem-
onstrated that microvascular resistance was the dom-
inant influence on angiography- derived FFR, above 
and beyond the severity or anatomy of epicardial 
disease.3 Hyperemic flow and minimal microvascular 
resistance are variable in health and disease and are 
hard to measure, even with invasive instrumentation. 
Noninvasive models of angiography- derived FFR 
therefore rely upon assumptions about these param-
eters, or predict them from surrogate markers such 
as arterial diameter. Again, empiric assumptions may 
be sufficient overall, for many cases, but will be inac-
curate in nonaverage cases with discordant anatomy 
and physiology, that is, the very cases where FFR 
is superior to angiography. Therefore, unless mod-
els have an accurate method for achieving this, on 
a patient- specific basis, the “physiological” predic-
tion becomes simply a function of stenosis geometry 
and they cannot be a genuine model of FFR at all 
(Figure). As an example, 1 study of angiographically 
derived FFR observed a significant reduction in di-
agnostic accuracy in patients with elevated micro-
vascular resistance.4 Paradoxically, physiologically 
weak models will appear more feasible relative to 
angiographic appearance, and a potential danger 
is that user confidence may therefore be increased 
with poorer methods. FFR has enabled a great stride 
forward in terms of physiologically guided revascu-
larization. It would be unfortunate if, in an attempt to 
increase physiological assessment, we were to take 
half a step back toward assessment based on epi-
cardial arterial anatomy. Table  2 summarizes major 
trials of angiography- derived FFR.4–18
ACCURACY AND ERROR RANGE
Headline validation results report “diagnostic” ac-
curacy. This quantifies how well a method predicts 
physiological significance or nonsignificance (FFR 
≤0.80), relative to invasive FFR, expressed as sensitiv-
ity, specificity, positive, and negative predictive values, 
area under a receiver operating curve, and overall di-
agnostic accuracy. Diagnostic accuracy is a function of 
(1) the method’s accuracy and (2) the cases included 
in a particular study. The fewer cases close to the 0.80 
threshold, the better the diagnostic accuracy will ap-
pear and vice versa. This is nicely illustrated in a study 
of FFR computed from computed tomography coro-
nary angiography in which the diagnostic accuracy 
was 82% overall, but only 46% in cases in FFR were 
0.70 to 0.80, which is precisely the range where most 
accuracy is required.19
The best test of how accurately angiography- 
derived FFR agrees with invasive FFR is to plot the 
Figure. Error in angiography- derived FFR. 
(A) An anatom ically severe circumflex case. In this case, the 
method applied an assumed value for microvascular resistance 
based on a population average, which resulted in considerable 
disagreement between angiography- derived and invasive FFR 
(0.55 vs 0.82). (B) Bland–Altman plot from a meta- analysis of 
13 studies (1842 vessels). There is minimal bias (gray line), but 
the ±95% limits of agreement were FFR ±0.14. FFR indicates 
fractional flow reserve. Reprinted from Collet et  al20 with 
permission. Copyright ©2018, Oxford University Press.
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Table 1. Angiography- Based Coronary Physiological Assessment Techniques
Index Abbreviation Calculated Equipment Potential Benefits Pitfalls/Limitations
Fractional flow 
reserve
FFR Whole cardiac cycle Pd/Pa 
at hyperemia
Pressure wire Predicts percentage improvement in flow with 
PCI. Good clinical outcomes data
Does not measure absolute flow and 
microvascular resistance
Instantaneous 
wave- free ratio/
resting full- cycle 
ratio
iFR/RFR Pd/Pa during diastolic 
phase
Pressure wire Good clinical outcome data, relative to FFR Does not measure absolute flow and 
microvascular resistance
Index of 
myocardial 
resistance
IMR (Pd) · (thermodilution 
derived mean transit time)
Thermo- and pressure-sensitive 
wire
Microvascular resistance becoming of increasing 
interest (eg, PCI nonresponders, ANOCA, AMI, 
HFpEF)
Thermodilution not widely used
Hyperemic 
microvascular 
resistance
HMR Pd/Doppler flow velocity Doppler and pressure wire Microvascular resistance becoming of increasing 
interest (eg, PCI nonresponders, ANOCA, AMI, 
HFpEF)
Doppler flow velocity challenging to 
measure. Doppler wires not widely used
Hyperemic 
stenosis 
resistance
HSR (Pa- Pd)/Doppler flow 
velocity
Doppler and pressure wire Objective, direct measure of the resistance of 
proximal disease
Doppler flow velocity challenging to 
measure. Doppler wires not widely used. 
Surrogate index
Angiography- 
derived FFR
vFFR/FFRangio/QFR Fluid dynamics equations 
informed by anatomy
Computational fluid dynamics 
software
Delivering clinical benefits of FFR without factors 
that limit the invasive technique
Relatively wide Bland–Altman limits of 
agreement compared with FFR. Requires 
excellent angiography. Less accurate in 
those with nonaverage microvascular 
resistance
CT- derived FFR CTFFR Fluid dynamics equations 
informed by anatomy
Computational fluid dynamics 
software (offline)
Reduce the number of unnecessary invasive 
catheterizations
Relatively wide Bland–Altman limits of 
agreement compared with FFR 
Coronary flow 
reserve
CFR (Hyperemic flow surrogate)/
(baseline flow surrogate) 
Flow derived from Doppler 
velocity or thermodilution 
mean transit time
Doppler or thermosensitive 
wire
A surrogate for flow and vasodilatory reserve. 
Flow more important than pressure, but hard to 
measure
Prone to same limitations as those for 
Doppler wire or thermodilution. Variability 
in baseline measurement can impair 
interpretation
Absolute 
coronary flow
Qb Infusion flow · (infusion 
temp/sensor temp) · 1.08 
During continuous saline 
infusion
Thermosensitive wire, pressure 
wire, monorail infusion catheter
Predicts absolute (not percentage) coronary flow 
changes and microvascular resistance
Additional time, expertise, and hardware 
All physiological indices are surrogate markers of physiology derived from other measures. AMI indicates acute myocardial infarction; ANOCA, angina and no obstructive coronary artery disease; FFR, fractional flow 
reserve; HFpEF, heart failure with preserved ejection fraction; MVR, microvascular resistance; Pa, proximal pressure; PCI, percutaneous coronary intervention; Pd, distal coronary pressure; and QFR, quantitative flow 
ratio.
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Table 2. Major Trials/Studies of Angiographically Derived FFR
Author Study Year N=Arteries Surrogate/Software/Company Mathematical Solution Diagnostic Accuracy
95% 
Limits of 
Agreement
Morris et al5 VIRTU- 1 2013 35 vFFR from VIRTUheart (University 
of Sheffield)
Transient 3D CFD 97% FFR ±0.16
Tu et al6 FAVOUR Pilot 2016 84 QFR from QAngio XA (Medis 
Medical Imaging Systems, NL)
Empiric flow velocity (fQFR), TIMI frame counting- 
derived contrast velocity at baseline (cQFR) and under 
hyperemia (aQFR). Analytical equations based on laws 
of Bernoulli and Poiseuille
fQFR 80% 
cQFR 86% 
aQFR 87%
FFR ±0.14 
FFR ±0.12 
FFR ±0.13
Kornowski et al7 FFRangio FIM 2016 101 FFRangio (CathWorks, Israel) Simple analytical equation, based on law of Poiseuille 94% FFR ±0.10
Trobs et al8 FFRangio 2016 100 FFRangio from Syngo IZ3D and 
prototype software (Siemens 
Healthcare GmbH, Germany)
CFD based on BP, anatomy, and literature estimates of 
microvascular resistance
90% FFR ±0.13
Pellicano et al9 FFRangio validation 2017 203 FFRangio (CathWorks, Israel) Simple analytical equation, based on law of Poiseuille 93% FFR ±0.10
Xu et al10 FAVOUR II China 2017 328 QFR from QAngio XA (Medis 
Medical Imaging Systems, NL)
TIMI frame counting- derived contrast velocity at 
baseline (cQFR). Analytical equations based on laws of 
Bernoulli and Poiseuille
93% FFR ±0.13
Yazaki et al11 QFR in intermediate 
lesions
2017 151 QFR from QAngio XA (Medis 
Medical Imaging Systems, NL)
TIMI frame counting- derived contrast velocity at 
baseline (cQFR). Analytical equations based on laws of 
Bernoulli and Poiseuille
88% FFR ±0.10
Westra et al12 WIFI II 2018 240 QFR from QAngio XA (Medis 
Medical Imaging Systems, NL)
TIMI frame counting- derived contrast velocity at 
baseline (cQFR). Analytical equations based on laws of 
Bernoulli and Poiseuille
83% FFR ±0.16
Mejía- Rentería 
et al4
QFR IMR study 2018 300 QFR from QAngio XA (Medis 
Medical Imaging Systems, NL)
TIMI frame counting- derived contrast velocity at 
baseline (cQFR). Analytical equations based on laws of 
Bernoulli and Poiseuille
IMR <23 =88% 
IMR ≥23 =76%
FFR ±0.12 
FFR ±0.15
Westra et al13 FAVOUR II EJ 2018 317 QFR from QAngio XA (Medis 
Medical Imaging Systems, NL)
TIMI frame counting- derived contrast velocity at 
baseline (cQFR). Analytical equations based on laws of 
Bernoulli and Poiseuille
87% FFR ±0.12
Fearon et al14 FAST- FFR 2019 319 FFRangio (CathWorks, Israel) Simple analytical equation, based on law of Poiseuille 92% FFR ±0.13
Omori et al15 FFRangio in 
multivessel disease
2019 118 FFRangio (CathWorks, Israel) Simple analytical equation, based on law of Poiseuille 92% FFR ±0.14
Stahli et al16 All comer QFR 2019 516 QFR from QAngio XA (Medis 
Medical Imaging Systems, NL)
TIMI frame counting- derived contrast velocity at 
baseline (cQFR). Analytical equations based on laws of 
Bernoulli and Poiseuille
93% FFR ±0.07
Masdjedi et al17 FAST- study 2019 100 vFFR from 3D QCA software, 
CAAS workstation (PIE Medical 
Imaging, NL)
Simple analytical equation, based on laws of Bernoulli 
and Poiseuille
AUC=0.93 FFR ±0.07
Li et al18 FLASH- FFR 2019 328 caFFR from FlashAngio (Rainmed 
Ltd, China)
CFD based on postangiography TIMI frame counting of 
flow velocity
96% FFR ±0.10
Listed in chronological order. Invasive FFR (threshold ≤0.80) was comparator in each study. 3D indicates 3- dimensional; aQFR, adenosine QFR; AUC, area under the curve; BP, blood pressure; caFFR, coronary 
angiography–derived fractional flow reserve; CFD, computational fluid dynamics; cQFR, contrast QFR; EJ, Europe and Japan; FFR, fractional flow reserve; FFRangio, FFR derived from coronary angiography; FIM, first in 
man; fQFR, fixed QFR; IMR, index of microcirculatory resistance; QFR, quantitative flow ratio; TIMI, thrombolysis in myocardial infarction; and vFFR, virtual fractional flow reserve.
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differences between predicted and observed FFR 
values against the mean (ie, a Bland–Altman plot). 
From this, the mean difference (delta), which quanti-
fies any bias in the angiography- derived method, and 
the 95% limits of agreement, are calculated. The limits 
of agreement (±1.96 SDs) comprise 95% of observed 
differences and are akin to the 95% CI of a computed, 
angiography- derived FFR result or an error range 
(Figure). The wider the limits of agreement, the larger 
the method’s error and vice versa. Unlike diagnostic 
accuracy, the limits of agreement are only a function of 
how accurate a method is. A recent meta- analysis of 
13 studies of angiography- derived FFR demonstrated 
impressive diagnostic accuracy (sensitivity, 89%; 
specificity, 90%), but more- sobering agreement, with 
limits of agreement of FFR ±0.14.20 This is remarkably 
similar to FFR computed from computed tomography 
in the NXT trial (limits of agreement FFR ±0.15).21 FFR 
computed from computed tomography, however, is a 
noninvasive screening tool, best used to reduce un-
necessary invasive catheterization. Arguably, the ac-
curacy “bar” should be set far higher for a test in the 
catheter laboratory, where results directly influence 
decisions regarding proceeding to percutaneous or 
surgical intervention. Is FFR ±0.14 accurate enough for 
interventional decision making? It is likely that noninferi-
ority trials will be used to assess these methods. These 
should avoid the usual pitfalls and be appropriate in 
terms of power, significance, analysis protocol, sample 
size, patient population, and prespecified noninferiority 
margins. Moreover, it remains to be seen how accu-
rate and reproducible these methods are, beyond aca-
demic core laboratories, in the hands of those who will 
be expected to use these tools (ie, the interventional 
cardiologist operating in the catheter laboratory).
CONCLUSIONS
Angiography- derived FFR has the potential to change 
clinical practice for the considerable benefit of patients 
by providing routine physiological data, together with 
coronary anatomy, to provide personalized manage-
ment and improved clinical outcomes. However, de-
riving physiology from anatomy is challenging and 
requires assumptions. Model simplification and physi-
ological assumptions, based on extrapolated or aver-
aged data, are likely to work in the majority of patients. 
However, much of FFR’s success lies in its ability to 
identify those cases where nonstandard microvascu-
lar resistance and/or flow result in discordant physiol-
ogy and anatomy. It is therefore important that models 
of angiography- derived FFR retain the same patient- 
specific physiology that separates traditional FFR from 
angiography, or at least that they highlight which cases 
require more- reliable assessment. Operators must 
understand how accuracy and error are defined in all 
patient groups. Stringent validation is required to prove 
that models are accurate and physiologically sound, in 
the hands of those who will be using them. If this can 
be achieved, clinicians have the potential to achieve 
what could be a new level of patient- specific medicine.
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